Open AccessAnalysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia Shows High Patient Heterogeneity and the Need for More Consideration of Individualized Treatment
Author(s) -
Xiaoli Xu,
Ying Zhao,
Haiyan Ye,
Yonglei Qi,
Wenning Xu,
Yiwen Ling,
Shaojiang Yang
Publication year - 2022
Publication title -
computational and mathematical methods in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.462
H-Index - 48
eISSN - 1748-6718
pISSN - 1748-670X
DOI - 10.1155/2022/7451395
Subject(s) - chemoimmunotherapy , fludarabine , rituximab , chronic lymphocytic leukemia , cyclophosphamide , medicine , leukemia , oncology , immunology , chemotherapy , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom